Effect of eptifibatide on angiographic complications during percutaneous coronary intervention in the IMPACT- (Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis) II trial

American Journal of Cardiology

Volumn 88, Issue 9, 2001, Pages 969-973

  Blankenship, James C ^a   Sigmon, Kristina N ^b   Pieper, Karen S ^b   O'Shea, Conor ^b   Tardiff, Barbara E ^b   Tcheng, James E ^b  

^a GEISINGER MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; PLACEBO;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DISSECTION; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME RELEASE; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION INHIBITION; THROMBUS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CREATINE KINASE; CREATINE KINASE, MB FORM; HUMANS; ISOENZYMES; PEPTIDES; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RANDOMIZED CONTROLLED TRIALS;

EID: 0035499813     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)01972-5     Document Type: Article

References (20)

1. Randomized placebo-controlled trial of effect of integrelin on complications of percutaneous coronary intervention: IMPACT II
2. Prognostic implications of creatine kinase elevation following elective coronary interventions
3. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions
4. Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting
5. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty
6. Periprocedural cardiac marker elevation after percutaneous coronary artery revascularization
7. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention
8. Incidence and mechanism of creatine kinase-MB enzyme elevation after coronary intervention with different devices
9. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions
10. Long-term clinical events following creatine-kinase myocardial band isoenzyme elevation after successful coronary stenting
11. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
12. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
13. Randomized placebo-controlled and balloon-angioplasty controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade
14. Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris
15. Coronary embolization after balloon angioplasty or thrombolytic therapy: An autopsy study of 32 cases
16. Angiographic evolution of intracoronary thrombus and dissection following percutaneous transluminal coronary angioplasty (the TAUSA trial)
17. Serial angioscopic and angiographic observations during the first hour after successful coronary angioplasty: A preamble to a multicenter trial addressing angioscopic marker for restenosis
18. Recognition of the importance of embolization in atherosclerotic vascular disease
19. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
20. A randomised, placebo-controlled trial of a novel dosing regimen of eptifibatide in planned coronary stent implantation